Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-172323
Filing Date
2010-07-30
Accepted
2010-07-30 17:04:46
Documents
11
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 581491
2 CERTIFICATION OF CEO, SECTION 302 dex311.htm EX-31.1 9211
3 CERTIFICATION OF CFO, SECTION 302 dex312.htm EX-31.2 9222
4 CERTIFICATION OF CEO, SECTION 906 dex321.htm EX-32.1 3911
5 CERTIFICATION OF CFO, SECTION 906 dex322.htm EX-32.2 3949
  Complete submission text file 0001193125-10-172323.txt   2232400

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alxn-20100630.xml EX-101.INS 225997
7 XBRL TAXONOMY EXTENSION SCHEMA alxn-20100630.xsd EX-101.SCH 12979
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alxn-20100630_cal.xml EX-101.CAL 35481
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alxn-20100630_def.xml EX-101.DEF 95602
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxn-20100630_lab.xml EX-101.LAB 114258
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxn-20100630_pre.xml EX-101.PRE 112900
Mailing Address 352 KNOTTER DRIVE CHESHIRE CT 06511
Business Address 352 KNOTTER DRIVE CHESHIRE CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Filer) CIK: 0000899866 (see all company filings)

EIN.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27756 | Film No.: 10981877
SIC: 2834 Pharmaceutical Preparations